Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001765581-23-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-07 | 2023-03-05 | JAZZ | Pearce Samantha | SVP, Head of Europe, Internat | F - Tax | $142.78 | -2,020 | 13.2K | -13% | -$288.4K | |
| 2023-03-07 | 2023-03-03 | JAZZ | Pearce Samantha | SVP, Head of Europe, Internat | A - Grant | $0.00 | +3,870 | 15.2K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-05 | F | D | 2,020 | $142.78 | 13,159 | D | — | — | |
| 2 | Common | Ordinary Shares | 2023-03-03 | A | A | 3,870 | $0.00 | 15,179 | D | — | — |